Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study-Reference-Cited by-同舟云学术

Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study

Published:2021-12-17 Issue: Volume: Page:
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Abdul Razak Albiruni R.,Bauer Sebastian^ORCID,Suarez Cristina,Lin Chia-Chi^ORCID,Quek Richard,Hütter-Krönke Marie Luise,Cubedo Ricardo,Ferretti Stephane,Guerreiro Nelson,Jullion Astrid,Orlando Elena J.,Clementi Giorgia,Sand Dejmek Janna,Halilovic Ensar,Fabre Claire,Blay Jean-Yves^ORCID,Italiano Antoine

Funder

Novartis Pharmaceuticals Corporation

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular characteristics and systemic treatment options of liposarcoma: A systematic review;Biomedicine & Pharmacotherapy;2024-09

2. Role of CDK4 as prognostic biomarker in Soft Tissue Sarcoma and synergistic effect of its inhibition in dedifferentiated liposarcoma sequential treatment;Experimental Hematology & Oncology;2024-08-05

3. Comprehensive Analysis of a Six-Gene Signature Predicting Survival and Immune Infiltration of Liposarcoma Patients and Deciphering Its Therapeutic Significance;International Journal of Molecular Sciences;2024-07-16

4. Clinical practice recommendations for the use of next-generation sequencing in patients with solid cancer: a joint report from KSMO and KSP;Journal of Pathology and Translational Medicine;2024-07-15

5. Proteomic profiling improves prognostic risk stratification of the Sarculator nomogram in soft tissue sarcomas of the extremities and trunk wall;Cancer Medicine;2024-07